World community hails Cadila's 'blockbuster' drug-Economic Times, Cadila Pharma eyes Rs 80 crore from Risorine: Business Standard, Cadila eyes Rs 100 cr sales from anti TB drugs in two years: DNA Money, Cadila may tap Chinese market with new combo drug for TB: The Economic Times, Cadila launches new drug for TB treatment: the Times of India, Cadila prescribes new drug for TB: The Hindu Business Line, Cadila Pharmaceuticals develops indigenous drug for TB patients : Indian Express.com, Cadila pharma, Novavax form Rs100 Crore JV co-THE TIMES OF INDIA
Welcome to Cadila Pharmaceuticals
Print

Vision

"Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment."

Mission

"We will discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases.

We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development.

We are responsible to the society. We shall be good corporate citizens and will be driven by high ethical standards in our practices."

 
 
 



'All over the world, response to the research findings on Polycap is overwhelming. This is a proud moment for me as an Indian that an Indian Pharmaceutical company has worked hard to achieve this feat. However, there are many more firsts-in-the-world yet to come from us,' Chairman- I. A. Modi

Over to Polycap ....

Login